Jiménez-López, J, Bazan, V, Gonzalez-Matos, CE, Di Marco, A, Bottoni, N, Battista, A, Giacoman, S, Sanchez-Millán, PJ, Lozano, JM, Alvarez-López, M, Belarte-Tornero, LC, Anguera, I, Casteigt, BJ, Sarrias-Mercé, A, Weidmann, ZM, Alonso-Martín, C, Llorca, L, Vallés-Gras, E. Targeting confluent areas of slow conduction and electrogram fragmentation for atrioventricular node re-entrant tachycardia ablation. EUROPACE. 2024; 26(5)DOI:10.1093/europace/euae094. PMID:38606815. IF:7.400(Q1/2D).

Tawil, R, Wagner, KR, Hamel, J, Leung, DG, Statland, JM, Wang, LH, Genge, A, Sacconi, S, Lochmüller, H, Reyes-Leiva, D, Diaz-Manera, J, Alonso-Perez, J, Muelas, N, Vilchez, JJ, Pestronk, A, Gibson, S, Goyal, NA, Hayward, LJ, Johnson, N, LoRusso, S, Freimer, M, Shieh, PB, Subramony, SH, van Engelen, B, Kools, J, Leinhard, OD, Widholm, P, Morabito, C, Moxham, CM, Cadavid, D, Mellion, ML, Odueyungbo, A, Tracewell, WG, Accorsi, A, Ronco, L, Gould, RJ, Shoskes, J, Rojas, LA, Jiang, JG. Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial. LANCET NEUROLOGY. 2024; 23(5)DOI:10.1016/S1474-4422(24)00073-5. PMID:38631764. IF:45.500(Q1/1D).

Garcia-Marti G., Escarti M.J., Nacher J., Perez-Rando M., Mane A., Usall J., Berrocoso E., Pomarol-Clotet E., Lopez-Ilundain J.M., Cuesta M.J., Rodriguez-Jimenez R., Gonzalez-Pinto A., Mar L., Ibañez A., Roldan A., Janssen J., Parellada M., Amoretti S., Bernardo M., Sanjuan J., Aguilar E.J.. Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinations. SCHIZOPHRENIA RESEARCH. 2024; 267DOI:10.1016/j.schres.2023.11.011. PMID:38044223. IF:3.500(Q1/3D).

Llorca-Bofí, V, Madero, S, Amoretti, S, Cuesta, MJ, Moreno, C, González-Pinto, A, Bergé, D, Rodriguez-Jimenez, R, Roldán, A, García-León, MA, Ibáñez, A, Usall, J, Contreras, F, Mezquida, G, García-Rizo, C, Berrocoso, E, Bernardo, M, Bioque, M. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia. SCHIZOPHRENIA RESEARCH. 2024; 267DOI:10.1016/j.schres.2024.03.011. PMID:38513331. IF:3.500(Q1/3D).